Testing effectiveness (Phase 2)WithdrawnNCT02297425
What this trial is testing
Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer
Who this might be right for
Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLC
Pfizer
Showing 2 of 2 results